FAQ : Tata India Pharma & Healthcare Fund - Regular Plan - Growth

Tata India Pharma & Healthcare Fund - Regular Plan - Growth has delivered CAGR and average rolling returns as follows :

1 Year 3 Year 5 Year 9 Year
CAGR(%) 47.48 18.33 22.43 N/A
Average Rolling Returns(%) 13.13 14.64 14.04 N/A

The Current NAV of Tata India Pharma & Healthcare Fund - Regular Plan - Growth is ₹25.50.

You can consider SIP in Tata India Pharma & Healthcare Fund - Regular Plan - Growth as it has consistently outperformed the benchmark and has a Very good quality portfolio. Funds returns are more likely to be different than its benchmark NIFTY PHARMA returns, as Funds portfolio is significantly different.

Tata India Pharma & Healthcare Fund - Regular Plan - Growth fund’s expense ratio is 2.27%

The process for redemption is

  • Give a request for redemption of the number of units or the amount you want. The request will be acknowledged.
  • You will get information about the redemption and the NAV at which redeemed.
  • The amount will be deposited in the designated bank account.

The AUM of Tata India Pharma & Healthcare Fund - Regular Plan - Growth is currently ₹843 Crores.

The Top three stocks are Sun Pharma Inds., Lupin and Aurobindo Pharma and account for 33% of its portfolio. Top 5 and 10 stocks of fund account for 45% and 66% of fund’s portfolio respectively.

Top three sectors of Tata India Pharma & Healthcare Fund - Regular Plan - Growth fund are Healthcare, Miscellaneous and Chemicals accounting for 100% of the total portfolio.

Funds Portfolio Quality is Very Good. It has a large proportion of Green Stocks.Since this is a Equity - Sectoral Fund - Pharma & Health Care it is comparatively safer to invest in this fund. However, since it has not consistently outperformed its benchmark index on an average 3-year rolling returns basis it is not the most suitable fund for SIP.

The category of Tata India Pharma & Healthcare Fund - Regular Plan - Growth Fund is Equity - Sectoral Fund - Pharma & Health Care.

Meeta Shetty manages the Tata India Pharma & Healthcare Fund - Regular Plan - Growth Fund.

Tata India Pharma & Healthcare Fund - Regular Plan - Growth current PE ratio is 48.03 and PB ratio is 5.86

The asset allocation of Tata India Pharma & Healthcare Fund - Regular Plan - Growth is Stocks : 95.06%, Debt : 4.92% and Gold : 0%

The minimum SIP amount for Tata India Pharma & Healthcare Fund - Regular Plan - Growth is ₹100.00 and minimum lumpsum is ₹5000.00

The exit load for Tata India Pharma & Healthcare Fund - Regular Plan - Growth is 0.25% on or before 30 days

© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.